References
- [No authors listed]Who are candidates for prevention and treatment for osteoporosis?Osteoporos Int19977116
- YoshimuraNMurakiSOkaHPrevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability studyJ Bone Miner Metab200927562062819568689
- United NationsWorld Mortality Report 2011New YorkUN2012 Available from: http://www.un.org/esa/population/publications/worldmortalityreport2011/World%20Mortality%20Report%202011.pdfAccessed June 13, 2013
- Statistics JapanCurrent population estimates as of October 1, 2012 Available from: http://www.stat.go.jp/english/data/jinsui/2012np/index.htmAccessed June 13, 2013
- MarshallDJohnellOWedelHMeta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ19963127041125412598634613
- BriggsAMGreigAMWarkJDThe vertebral fracture cascade in osteoporosis: a review of aetiopathogenesisOsteoporos Int200718557558417206492
- KlotzbuecherCMRossPDLandsmanPBAbbottTA3rdBergerMPatients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesisJ Bone Miner Res200015472173910780864
- LindsayRBurgeRTStraussDMOne year outcomes and costs following a vertebral fractureOsteoporos Int2005161788515167988
- IkedaYSudoAYamadaTUchidaAMortality after vertebral fractures in a Japanese populationJ Orthop Surg (Hong Kong)201018214815220808003
- JinbayashiHAoyagiKRossPDItoMShindoHTakemotoTPrevalence of vertebral deformity and its associations with physical impairment among Japanese women: the Hizen-Oshima StudyOsteoporos Int200213972373012195536
- MiyakoshiNHongoMMaekawaSIshikawaYShimadaYItoiEBack extensor strength and lumbar spinal mobility are predictors of quality of life in patients with postmenopausal osteoporosisOsteoporos Int200718101397140317460805
- MiyakoshiNItoiEKobayashiMKodamaHImpact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosisOsteoporos Int200314121007101214557854
- SuzukiNOgikuboOHanssonTPrevious vertebral compression fractures add to the deterioration of the disability and quality of life after an acute compression fractureEur Spine J201019456757419760437
- TakahashiTIshidaKHiroseDTrunk deformity is associated with a reduction in outdoor activities of daily living and life satisfaction in community-dwelling older peopleOsteoporos Int200516327327915235766
- FujiwaraSKasagiFMasunariNNaitoKSuzukiGFukunagaMFracture prediction from bone mineral density in Japanese men and womenJ Bone Miner Res20031881547155312929946
- European Prospective Osteoporosis Study GroupFelsenbergDSilmanAJIncidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS)J Bone Miner Res200217471672411918229
- Van der KliftMDe LaetCEMcCloskeyEVHofmanAPolsHAThe incidence of vertebral fractures in men and women: the Rotterdam StudyJ Bone Miner Res20021761051105612054160
- MithalAEbelingPThe Asia-Pacific Regional Audit. Epidemiology, Costs and Burden of Osteoporosis in 2013Nyon, SwitzerlandInternational Osteoporosis Foundation2013 Available from: http://www.iofbonehealth.org/sites/default/files/media/PDFs/Regional%20Audits/2013-Asia_Pacific_Audit_0_0.pdfAccessed August 5, 2014
- Committee of Japanese Guidelines for the Prevention and Treatment of OsteoporosisJapanese Guidelines for the Prevention and Treatment of OsteoporosisTokyoLife Science2011
- HaradaAMatsuiYMizunoMTokudaHNiinoNOhtaTJapanese orthopedists’ interests in prevention of fractures in the elderly from fallsOsteoporos Int200415756056615067499
- IwamotoJSatoYTakedaTMatsumotoHEfficacy of antiresorptive agents for preventing fractures in Japanese patients with an increased fracture risk: review of the literatureDrugs Aging201229319120322372723
- CranneyAAdachiJDBenefit-risk assessment of raloxifene in postmenopausal osteoporosisDrug Saf200528872173016048357
- KanisJAJohnellOBlackDMEffect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trialBone200333329330013678769
- TakadaJMikiTImanishiYEffects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosisJ Bone Miner Metab201028556156720333418
- Uusi-RasiKBeckTJSemanickLMStructural effects of raloxifene on the proximal femur: results from the Multiple Outcomes of Raloxifene Evaluation TrialOsteoporos Int200617457558616392026
- SaitoMMarumoKSoshiSKidaYUshikuCShinoharaARaloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemiaOsteoporos Int201021465566619484165
- BoivinGLipsPOttSMContribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal womenJ Clin Endocrinol Metab20038894199420512970287
- NakamuraTLiuJLMoriiHEffect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosisJ Bone Miner Metab200624541441816937275
- GoraiITanakaYHattoriSIwaokiYAssessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese womenJ Bone Miner Metab201028217618419657590
- AndoHOtodaTOokamiHDosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosisClin Exp Pharmacol Physiol201340322723223323567
- IwamotoJSatoYUzawaMTakedaTMatsumotoHComparison of effects of alendronate and raloxifene on lumbar bone mineral density, bone turnover, and lipid metabolism in elderly women with osteoporosisYonsei Med J29200849111912818306478
- GoraiIHattoriSTanakaYIwaokiYAlfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopeniaJ Bone Miner Metab201230334935822130786
- MajimaTKomatsuYShimatsuAEfficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosisEndocr J200855112713418219181
- HayashiTInaKMaedaMNomuraHThe effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosisNitric Oxide201124419920321513812
- MoriiHOhashiYTaketaniYEffect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trialOsteoporos Int2003141079380012955333
- MajimaTKomatsuYShimatsuAClinical significance of 1-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosisEndocr J200754685586217917307
- MajimaTShimatsuAKomatsuYAssociation between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosisEndocr J2008b551414818187874
- MajimaTShimatsuASatohNThree-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosisJ Bone Miner Metab200826217818418301975
- TakadaJIbaKYoshizakiTYamashitaTCorrelation between a bone resorption marker and structural geometry of the proximal femur in osteoporotic women treated with raloxifeneJ Orthop Surg (Hong Kong)201220220921322933681
- IikuniNHamayaENihojimaSSafety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillanceJ Bone Miner Metab201230667468222752125
- UrushiharaHKikuchiNYamadaMYoshikiFMiyauchiARaloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillanceMenopause200916597197719357545
- YohKHamayaEUrushiharaHQuality of life in raloxifene-treated Japanese women with postmenopausal osteoporosis: a prospective, postmarketing observational studyCurr Med Res Opin201228111757176623035693
- OrimoHHayashiYFukunagaMDiagnostic criteria for primary osteoporosis: year 2000 revisionJ Bone Miner Metab200119633133711685647
- Eli Lilly JapanEvista [package insert]Kobe, JapanEli Lilly Japan2007
- DutertreMSmithCLMolecular mechanisms of selective estrogen receptor modulator (SERM) actionJ Pharmacol Exp Ther2000295243143711046073
- EttingerBBlackDMMitlakBHReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA1999282763764510517716
- DelmasPDEnsrudKEAdachiJDEfficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trialJ Clin Endocrinol Metab20028783609361712161484
- QuYWongMThiebaudDStockJLThe effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trialCurr Med Res Opin200521121955195916368046
- KikuchiTEffect of combination therapy with eldecalcitol and raloxifene on bone metabolism in osteoporotic patientsTher Res201233914231429 Japanese
- TakedaSSakaiSShiraishiAKoikeNMiharaMEndoKCombination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized ratsBone201353116717323232307
- KanisJAJohnellOOdenAThe risk and burden of vertebral fractures in SwedenOsteoporos Int2004151202614593450
- RossPDFujiwaraSHuangCVertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the USInt J Epidemiol1995246117111778824859
- KwokAWLeungJCChanAYPrevalence of vertebral fracture in Asian men and women: comparison between Hong Kong, Thailand, Indonesia and JapanPublic Health2012126652353122560410
- ItoMNishidaAUetaniMHayashiKOsteoporosis in the Japanese populationSemin Musculoskelet Radiol20015212112611500152
- Centers for Disease Control and PreventionOsteoporosis Available from: http://www.cdc.gov/nchs/data/nhanes/databriefs/osteoporosis.pdfAccessed June 14, 2013
- HuangCRossPDFujiwaraSDeterminants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in HawaiiBone19961854374428739901
- MoritaAGenetic factors of osteoporosis and fracture and the application of genetic information to the preventive medicineClin Calcium200515813641371 Japanese16062007
- MasakiHMikiTBone and calcium metabolism in elderly womenClin Calcium201121913611367 Japanese21881199
- NakamuraKKurahashiNIshiharaJInoueMTsuganeSCalcium intake and the 10-year incidence of self-reported vertebral fractures in women and men: the Japan Public Health Centre-based Prospective StudyBr J Nutr2009101228529418549509
- OhishiHNakamuraYKishiyaMTohSSpontaneous femoral neck fracture associated with a low serum level of vitamin DJ Orthop Sci201318349649922057737
- FujiwaraSHamayaEGotoWVertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk in JapanBone201149352052521652001
- BeckTJRuffCBWardenKEScottWWJrRaoGUPredicting femoral neck strength from bone mineral data. A structural approachInvest Radiol19902516182298552
- BeckTJLookerACRuffCBSievanenHWahnerHWStructural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry dataJ Bone Miner Res200015122297230411127194
- BeckTJRuffCBBissessurKAge-related changes in female femoral neck geometry: implications for bone strengthCalcif Tissue Int199353Suppl 1S41S468275379
- BeckTJRuffCBScottWWJrPlatoCCTobinJDQuanCASex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral dataCalcif Tissue Int199250124291739866
- TakadaJBeckTJIbaKYamashitaTStructural trends in the aging proximal femur in Japanese postmenopausal womenBone20074119710217513185
- WangXFDuanYBeckTJSeemanEVarying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old ageBone200536697898615869919
- BeckTJLewieckiEMMillerPDEffects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronateJ Clin Densitom200811335135918495508
- BonnickSLBeckTJCosmanFHochbergMCWangHde PappAEDXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone massOsteoporos Int200920691192118830555
- GreenspanSLWymanAHoovenFHPredictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal womenJ Am Geriatr Soc201260345546122316070
- Uusi-RasiKSemanickLMZanchettaJREffects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic womenBone200536694895815878318
- GradyDEttingerBMoscarelliESafety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluationObstet Gynecol2004104483784415458908
- KamibayashiJCurrent State of Therapy for Deep Venous Thrombosis and Pulmonary Embolism at Special Centers in JapanStudy Report 55–58TokyoAbnormal Blood Coagulation Study Group, Ministry of Health, Labour and Welfare, Japan1995
- HamayaESowaHRe: Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillanceMenopause201421110911024281238
- Barrett-ConnorEMoscaLCollinsPEffects of raloxifene on cardiovascular events and breast cancer in postmenopausal womenN Engl J Med2006355212513716837676
- MasunariNFujiwaraSNakataYNakashimaENakamuraTHistorical height loss, vertebral deformity, and health-related quality of life in Hiroshima cohort studyOsteoporos Int200718111493149917541811
- HaginoHNakamuraTFujiwaraSOekiMOkanoTTeshimaRSequential change in quality of life for patients with incident clinical fractures: a prospective studyOsteoporos Int200920569570218836672
- IbaKTakadaJHatakeyamaNUnderutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fractureJ Orthop Sci200611544644917013730